|
Life Sciences Intellectual Property Review - Annual Editions - Free Content
2011 Edition
- Life sciences in Europe: the key jurisdictions
- An interview with BIO president Jim Greenwood
- How shifting IP laws change the global life sciences regulatory chessboard
- US patent law changes appear imminent
- Patenting genes and diagnostics
- A revolution: biotech patents in India
View the digital edition FREE
2010 Edition
- Gene patents - Myriad ruling could threaten the health of an entire industry
- Stem cell research - European Court of Justice faces crucial decision
- Patent owners alert - Brazil may leave blockbuster drugs without patent protection
- Strict examinations - Canada's rules on patents highlighted by two cases
- New rules for French patents - criteria changes in courts of France
View the digital edition FREE
2009 Edition
- Patent reform - BIO looks at the impact of recent patent reform in the US on biotechnology innovation and commercialisation
- The vaccine industry has been slow to embrace patent protection as a driver of innovation, but times are changing for this unique industry
- Thoughtful claim drafting may afford the patantee a stronger position in establishing infringement
View the digital edition FREE
2008 Edition
- Cross-border co-operation and addressing counterfeit medicines and pharmaceuticals in Latin America, Asia and worldwide
- Assuring the integrity of a supply chain against global threats
- How small life sciences start-ups should best plan and protect their IP to maximise the chances of success
- New prior are disclosure rules expected for patent filings - PTO rule changes may require life science companies to rethink patent filing strategies
View the digital edition FREE
|
|
|
|
|
